RDNTMEDIUM SIGNALOPERATIONAL10-K

RadNet expanded its imaging center footprint by 20 locations while restructuring its digital health segment branding and experiencing a significant decline in operating profitability despite revenue growth.

The company's operational expansion and rebranding of its digital health division from eRad to a broader "Digital Health operating segment" suggests strategic repositioning for growth in AI-enhanced imaging services. However, the substantial decline in operating income despite revenue growth raises questions about cost management and margin compression that warrant close monitoring.

Comparing 2026-03-02 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

RadNet delivered solid revenue growth of 13% to $1.6 billion while maintaining strong operational cash flow generation that increased 28% to $298.8 million. However, operating income declined meaningfully by 41% to $62.0 million, indicating significant margin pressure despite the top-line expansion. The balance sheet strengthened with total assets growing 14% to $3.8 billion and stockholders' equity increasing 21% to $1.1 billion, though current liabilities also rose 22%, reflecting the company's ongoing expansion investments.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-40.7%
$104.6M→$62.0M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Interest Expense
P&L
-30.2%
$86K→$60K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
+28.2%
$233.0M→$298.8M

Operating cash flow grew 28.2% — strong conversion of earnings to cash, healthy business fundamentals.

Current Liabilities
Balance Sheet
+22.3%
$479.7M→$586.8M

Current liabilities rose 22.3% — increased short-term obligations, watch current ratio.

Stockholders Equity
Balance Sheet
+20.8%
$902.3M→$1.1B

Equity base grew 20.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+14.4%
$3.3B→$3.8B

Asset base grew 14.4% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
+13%
$1.4B→$1.6B

Revenue growing 13% — solid top-line momentum, watch margins for quality of growth.

Total Liabilities
Balance Sheet
+11.6%
$2.2B→$2.4B

Liabilities increased 11.6% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-03-02
PRIOR — 2025-03-03
ADDED
As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.
Our services include magnetic resonance imaging ("MRI"), computed tomography ("CT"), positron emission tomography ("PET"), nuclear medicine, mammography, ultrasound, diagnostic radiology ("X-ray"), fluoroscopy and other related procedures.
Integral to the imaging center business is our Digital Health operating segment, which sells computerized systems that distribute, display, store and retrieve digital images.
We have also established a Digital Health segment division, that develops and deploys Artificial Intelligence ("AI") suites to enhance radiologist interpretations of, among others, breast, lung and prostate images.
In addition, AI methods can speed up administrative tasks, such as tracking of individuals who need procedures on a regular basis (i.e., mammograms, follow-up exams, etc.) and alerting our staff to contact the patient and schedule appointments.
+7 more — sign up free →
REMOVED
As of December 31, 2024, we operated, directly or indirectly through joint ventures with hospitals, 398 imaging centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, Texas and New York.
Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures.
Integral to the imaging center business is our software arm headed by our eRad, Inc.
subsidiary, which sells computerized systems that distribute, display, store and retrieve digital images.
We have also established an Artificial Intelligence (AI) division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NVDAHIGHNVIDIA has repositioned itself from a "full-stack computing infrastructure compa...
2026-02-25
NOWHIGHServiceNow has fundamentally repositioned itself as an AI-first platform company...
2026-01-29
TSLAHIGHTesla has fundamentally repositioned itself from an electric vehicle company to ...
2026-01-29
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →